Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 108 articles: HTML format

Single Articles

July 2022
1. REZEL-POTTS E, Douiri A, Sun X, Chowienczyk PJ, et al
   Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK.
   PLoS Med. 2022;19:e1004052.
   PubMed     Abstract available
   
   
   
2. COBB NL, Collier S, Attia EF, Augusto O, et al
   Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020.
   PLoS Med. 2022;19:e1004035.
   PubMed     Abstract available
   
   
   
3. SHIBUYA K, Tan CC, Chun AY, Leung GM, et al
   Global human security in the post-COVID-19 era: The rising role of East Asia.
   PLoS Med. 2022;19:e1003939.
   PubMed     Abstract available
   
   
   
4. HERNANDEZ I, Dickson S, Tang S, Gabriel N, et al
   Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
   PLoS Med. 2022;19:e1004069.
   PubMed     Abstract available
   
   
   
5. MASSARI M, Spila Alegiani S, Morciano C, Spuri M, et al
   Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
   PLoS Med. 2022;19:e1004056.
   PubMed     Abstract available
   
   
   June 2022
6. TAKUVA S, Takalani A, Seocharan I, Yende-Zuma N, et al
   Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
   PLoS Med. 2022;19:e1004024.
   PubMed     Abstract available
   
   
   
7. WONG CKH, Lau KTK, Xiong X, Au ICH, et al
   Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
   PLoS Med. 2022;19:e1004018.
   PubMed     Abstract available
   
   
   
8. CUIJPERS P, Heim E, Abi Ramia J, Burchert S, et al
   Effects of a WHO-guided digital health intervention for depression in Syrian refugees in Lebanon: A randomized controlled trial.
   PLoS Med. 2022;19:e1004025.
   PubMed     Abstract available
   
   
   
9. GRAIS RF, Baron E
   Addressing the impacts of COVID-19 on refugee health.
   PLoS Med. 2022;19:e1004050.
   PubMed    
   
   
   May 2022
10. MARTIN CA, Pan D, Melbourne C, Teece L, et al
    Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
    PLoS Med. 2022;19:e1004015.
    PubMed     Abstract available
    
    
    
11. JIN P, Guo X, Chen W, Ma S, et al
    Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.
    PLoS Med. 2022;19:e1003953.
    PubMed     Abstract available
    
    
    
12. VAN GILS MJ, Lavell A, van der Straten K, Appelman B, et al
    Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study.
    PLoS Med. 2022;19:e1003991.
    PubMed     Abstract available
    
    
    
13. ALTARE C, Kostandova N, OKeeffe J, Hayek H, et al
    COVID-19 epidemiology and changes in health service utilization in Azraq and Zaatari refugee camps in Jordan: A retrospective cohort study.
    PLoS Med. 2022;19:e1003993.
    PubMed     Abstract available
    
    
    
14. ANNWEILER C, Beaudenon M, Gautier J, Gonsard J, et al
    High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
    PLoS Med. 2022;19:e1003999.
    PubMed     Abstract available
    
    
    
15. BUITRAGO-GARCIA D, Ipekci AM, Heron L, Imeri H, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003987.
    PubMed     Abstract available
    
    
    
16. MACHADO DB, Williamson E, Pescarini JM, Alves FJO, et al
    Relationship between the Bolsa Familia national cash transfer programme and suicide incidence in Brazil: A quasi-experimental study.
    PLoS Med. 2022;19:e1004000.
    PubMed     Abstract available
    
    
    
17. BRUMMER LE, Katzenschlager S, McGrath S, Schmitz S, et al
    Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors.
    PLoS Med. 2022;19:e1004011.
    PubMed     Abstract available
    
    
    April 2022
18. FOO D, Sarna M, Pereira G, Moore HC, et al
    Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study.
    PLoS Med. 2022;19:e1003963.
    PubMed     Abstract available
    
    
    
19. WATKINSON RE, Williams R, Gillibrand S, Sanders C, et al
    Correction: Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    PLoS Med. 2022;19:e1003982.
    PubMed     Abstract available
    
    
    
20. WAINSTEIN M, MacDonald S, Fryer D, Young K, et al
    Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
    PLoS Med. 2022;19:e1003969.
    PubMed     Abstract available
    
    
    March 2022
21. WATKINSON RE, Williams R, Gillibrand S, Sanders C, et al
    Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    PLoS Med. 2022;19:e1003932.
    PubMed     Abstract available
    
    
    
22. WANG C, Ong JJ, Zhao P, Weideman AM, et al
    Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
    PLoS Med. 2022;19:e1003930.
    PubMed     Abstract available
    
    
    
23. MAURIN C, He Z, Mentek M, Verhoeven P, et al
    Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study.
    PLoS Med. 2022;19:e1003922.
    PubMed     Abstract available
    
    
    
24. GIMMA A, Munday JD, Wong KLM, Coletti P, et al
    Changes in social contacts in England during the COVID-19 pandemic between March 2020 and March 2021 as measured by the CoMix survey: A repeated cross-sectional study.
    PLoS Med. 2022;19:e1003907.
    PubMed     Abstract available
    
    
    February 2022
25. SAAKSVUORI L, Betsch C, Nohynek H, Salo H, et al
    Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland.
    PLoS Med. 2022;19:e1003919.
    PubMed     Abstract available
    
    
    
26. 
    Vaccine equity: A fundamental imperative in the fight against COVID-19.
    PLoS Med. 2022;19:e1003948.
    PubMed    
    
    
    
27. KONTOPANTELIS E, Mamas MA, Webb RT, Castro A, et al
    Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study.
    PLoS Med. 2022;19:e1003904.
    PubMed     Abstract available
    
    
    
28. CAUSEY K, Mosser JF
    Learning from the COVID-19 pandemic to strengthen routine immunization systems.
    PLoS Med. 2022;19:e1003934.
    PubMed     Abstract available
    
    
    
29. MCQUAID F, Mulholland R, Sangpang Rai Y, Agrawal U, et al
    Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data.
    PLoS Med. 2022;19:e1003916.
    PubMed     Abstract available
    
    
    
30. KERR S, Joy M, Torabi F, Bedston S, et al
    First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales.
    PLoS Med. 2022;19:e1003927.
    PubMed     Abstract available
    
    
    January 2022
31. GENTILE I, Schiano Moriello N
    COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination.
    PLoS Med. 2022;19:e1003917.
    PubMed     Abstract available
    
    
    
32. STRONGMAN H, Carreira H, De Stavola BL, Bhaskaran K, et al
    Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink.
    PLoS Med. 2022;19:e1003870.
    PubMed     Abstract available
    
    
    
33. BHASKARAN K, Rentsch CT, Hickman G, Hulme WJ, et al
    Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
    PLoS Med. 2022;19:e1003871.
    PubMed     Abstract available
    
    
    
34. QUINN KL, Bell CM
    Pandemic health consequences: Grasping the long COVID tail.
    PLoS Med. 2022;19:e1003891.
    PubMed    
    
    
    
35. GUROL-URGANCI I, Waite L, Webster K, Jardine J, et al
    Obstetric interventions and pregnancy outcomes during the COVID-19 pandemic in England: A nationwide cohort study.
    PLoS Med. 2022;19:e1003884.
    PubMed     Abstract available
    
    
    December 2021
36. GRAM MA, Nielsen J, Schelde AB, Nielsen KF, et al
    Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    PLoS Med. 2021;18:e1003874.
    PubMed     Abstract available
    
    
    
37. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Coyle P, et al
    Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
    PLoS Med. 2021;18:e1003879.
    PubMed     Abstract available
    
    
    
38. KARUNA S, Li SS, Grant S, Walsh SR, et al
    Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
    PLoS Med. 2021;18:e1003868.
    PubMed     Abstract available
    
    
    
39. PETERSEN M, Schwab J, Havlir DV
    SARS-CoV-2 vaccine boosters: The time to act is now.
    PLoS Med. 2021;18:e1003882.
    PubMed     Abstract available
    
    
    
40. MURHEKAR MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, et al
    Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    PLoS Med. 2021;18:e1003877.
    PubMed     Abstract available
    
    
    
41. SENEFELD JW, Johnson PW, Kunze KL, Bloch EM, et al
    Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.
    PLoS Med. 2021;18:e1003872.
    PubMed     Abstract available
    
    
    November 2021
42. MARTIN CA, Marshall C, Patel P, Goss C, et al
    SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    PLoS Med. 2021;18:e1003823.
    PubMed     Abstract available
    
    
    
43. BHANU C, Gopal DP, Walters K, Chaudhry UAR, et al
    Vaccination uptake amongst older adults from minority ethnic backgrounds: A systematic review.
    PLoS Med. 2021;18:e1003826.
    PubMed     Abstract available
    
    
    
44. EPELBOIN S, Labrosse J, De Mouzon J, Fauque P, et al
    Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
    PLoS Med. 2021;18:e1003857.
    PubMed     Abstract available
    
    
    
45. ABDOOL KARIM SS, Kelemu S, Baxter C
    COVID-19 in Africa: Catalyzing change for sustainable development.
    PLoS Med. 2021;18:e1003869.
    PubMed     Abstract available
    
    
    
46. SPLINTER MJ, Velek P, Ikram MK, Kieboom BCT, et al
    Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study.
    PLoS Med. 2021;18:e1003854.
    PubMed     Abstract available
    
    
    October 2021
47. STOVER J, Glaubius R, Teng Y, Kelly S, et al
    Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    PLoS Med. 2021;18:e1003831.
    PubMed     Abstract available
    
    
    
48. PEARSON CAB, Bozzani F, Procter SR, Davies NG, et al
    COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    PLoS Med. 2021;18:e1003815.
    PubMed     Abstract available
    
    
    
49. FORMICA N, Mallory R, Albert G, Robinson M, et al
    Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
    PLoS Med. 2021;18:e1003769.
    PubMed     Abstract available
    
    
    
50. BERGQVIST R, Ahlqvist VH, Lundberg M, Hergens MP, et al
    HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
    PLoS Med. 2021;18:e1003820.
    PubMed     Abstract available
    
    
    
51. GILBODY S, Littlewood E, McMillan D, Chew-Graham CA, et al
    Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial.
    PLoS Med. 2021;18:e1003779.
    PubMed     Abstract available
    
    
    
52. MO Y, Eyre DW, Lumley SF, Walker TM, et al
    Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.
    PLoS Med. 2021;18:e1003816.
    PubMed     Abstract available
    
    
    
53. IOANNOU GN, Ferguson JM, O'Hare AM, Bohnert ASB, et al
    Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.
    PLoS Med. 2021;18:e1003807.
    PubMed     Abstract available
    
    
    
54. POLLETT S, Johansson MA, Reich NG, Brett-Major D, et al
    Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines.
    PLoS Med. 2021;18:e1003793.
    PubMed     Abstract available
    
    
    
55. GENG EH, Reid MJA, Goosby E, Abdool-Karim Q, et al
    COVID-19 and global equity for health: The good, the bad, and the wicked.
    PLoS Med. 2021;18:e1003797.
    PubMed     Abstract available
    
    
    September 2021
56. FIGUEROA JP, Hotez PJ, Batista C, Ben Amor Y, et al
    Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
    PLoS Med. 2021;18:e1003772.
    PubMed     Abstract available
    
    
    
57. MUTHUKUMAR AV, Morrell W, Bierer BE
    Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov.
    PLoS Med. 2021;18:e1003758.
    PubMed     Abstract available
    
    
    
58. ELLIOTT J, Whitaker M, Bodinier B, Eales O, et al
    Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
    PLoS Med. 2021;18:e1003777.
    PubMed     Abstract available
    
    
    
59. TAQUET M, Dercon Q, Luciano S, Geddes JR, et al
    Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    PLoS Med. 2021;18:e1003773.
    PubMed     Abstract available
    
    
    
60. ADAM M, Johnston J, Job N, Dronavalli M, et al
    Evaluation of a community-based mobile video breastfeeding intervention in Khayelitsha, South Africa: The Philani MOVIE cluster-randomized controlled trial.
    PLoS Med. 2021;18:e1003744.
    PubMed     Abstract available
    
    
    August 2021
61. BRUMMER LE, Katzenschlager S, Gaeddert M, Erdmann C, et al
    Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003735.
    PubMed     Abstract available
    
    
    
62. KILMARX PH, Glass RI
    Building global health research capacity to address research imperatives following the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003753.
    PubMed     Abstract available
    
    
    July 2021
63. SULIS G, Batomen B, Kotwani A, Pai M, et al
    Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
    PLoS Med. 2021;18:e1003682.
    PubMed     Abstract available
    
    
    
64. IWANAMI S, Ejima K, Kim KS, Noshita K, et al
    Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study.
    PLoS Med. 2021;18:e1003660.
    PubMed     Abstract available
    
    
    
65. KANDULA S, Shaman J
    Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: A modeling study.
    PLoS Med. 2021;18:e1003693.
    PubMed     Abstract available
    
    
    June 2021
66. BUTLER-LAPORTE G, Nakanishi T, Mooser V, Morrison DR, et al
    Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
    PLoS Med. 2021;18:e1003605.
    PubMed     Abstract available
    
    
    
67. INZAULE SC, Ondoa P, Loembe MM, Tebeje YK, et al
    COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control.
    PLoS Med. 2021;18:e1003666.
    PubMed     Abstract available
    
    
    
68. MAO W, Ogbuoji O, Watkins D, Bharali I, et al
    Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.
    PLoS Med. 2021;18:e1003675.
    PubMed     Abstract available
    
    
    May 2021
69. GOLDMAN M, Hermans C
    Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.
    PLoS Med. 2021;18:e1003648.
    PubMed     Abstract available
    
    
    
70. STOKES AC, Lundberg DJ, Elo IT, Hempstead K, et al
    COVID-19 and excess mortality in the United States: A county-level analysis.
    PLoS Med. 2021;18:e1003571.
    PubMed     Abstract available
    
    
    April 2021
71. KRISHNAN A, Dar L, Saha S, Narayan VV, et al
    Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    PLoS Med. 2021;18:e1003609.
    PubMed     Abstract available
    
    
    
72. ABIMBOLA S, Asthana S, Montenegro C, Guinto RR, et al
    Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003604.
    PubMed     Abstract available
    
    
    
73. GRANTZ KH, Lee EC, D'Agostino McGowan L, Lee KH, et al
    Maximizing and evaluating the impact of test-trace-isolate programs: A modeling study.
    PLoS Med. 2021;18:e1003585.
    PubMed     Abstract available
    
    
    March 2021
74. LAFOND KE, Porter RM, Whaley MJ, Suizan Z, et al
    Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003550.
    PubMed     Abstract available
    
    
    
75. BALCELLS ME, Rojas L, Le Corre N, Martinez-Valdebenito C, et al
    Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
    PLoS Med. 2021;18:e1003415.
    PubMed     Abstract available
    
    
    
76. REID M, Abdool-Karim Q, Geng E, Goosby E, et al
    How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities.
    PLoS Med. 2021;18:e1003564.
    PubMed     Abstract available
    
    
    
77. LEONG A, Cole JB, Brenner LN, Meigs JB, et al
    Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
    PLoS Med. 2021;18:e1003553.
    PubMed     Abstract available
    
    
    January 2021
78. SELIGMAN B, Ferranna M, Bloom DE
    Social determinants of mortality from COVID-19: A simulation study using NHANES.
    PLoS Med. 2021;18:e1003490.
    PubMed     Abstract available
    
    
    December 2020
79. KIM MS, An MH, Kim WJ, Hwang TH, et al
    Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    PLoS Med. 2020;17:e1003501.
    PubMed     Abstract available
    
    
    October 2020
80. MAKARONIDIS J, Mok J, Balogun N, Magee CG, et al
    Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
    PLoS Med. 2020;17:e1003358.
    PubMed     Abstract available
    
    
    
81. MCKEIGUE PM, Weir A, Bishop J, McGurnaghan SJ, et al
    Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
    PLoS Med. 2020;17:e1003374.
    PubMed     Abstract available
    
    
    
82. BASSETT MT, Chen JT, Krieger N
    Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
    PLoS Med. 2020;17:e1003402.
    PubMed     Abstract available
    
    
    
83. KOLHE NV, Fluck RJ, Selby NM, Taal MW, et al
    Acute kidney injury associated with COVID-19: A retrospective cohort study.
    PLoS Med. 2020;17:e1003406.
    PubMed     Abstract available
    
    
    September 2020
84. LUND LC, Kristensen KB, Reilev M, Christensen S, et al
    Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
    PLoS Med. 2020;17:e1003308.
    PubMed     Abstract available
    
    
    
85. WHITE NJ, Watson JA, Hoglund RM, Chan XHS, et al
    COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    PLoS Med. 2020;17:e1003252.
    PubMed     Abstract available
    
    
    
86. HARRISON SL, Fazio-Eynullayeva E, Lane DA, Underhill P, et al
    Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
    PLoS Med. 2020;17:e1003321.
    PubMed     Abstract available
    
    
    
87. BUITRAGO-GARCIA D, Egli-Gany D, Counotte MJ, Hossmann S, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003346.
    PubMed     Abstract available
    
    
    
88. RENTSCH CT, Kidwai-Khan F, Tate JP, Park LS, et al
    Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
    PLoS Med. 2020;17:e1003379.
    PubMed     Abstract available
    
    
    
89. JUUL S, Nielsen EE, Feinberg J, Siddiqui F, et al
    Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    PLoS Med. 2020;17:e1003293.
    PubMed     Abstract available
    
    
    
90. STOWE J, Andrews N, Gringras P, Quinnell T, et al
    Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
    PLoS Med. 2020;17:e1003225.
    PubMed     Abstract available
    
    
    August 2020
91. BENJAMIN-CHUNG J, Arnold BF, Kennedy CJ, Mishra K, et al
    Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: A matched cohort study.
    PLoS Med. 2020;17:e1003238.
    PubMed     Abstract available
    
    
    
92. SIEDNER MJ, Harling G, Reynolds Z, Gilbert RF, et al
    Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest-posttest comparison group study.
    PLoS Med. 2020;17:e1003244.
    PubMed     Abstract available
    
    
    
93. HARRINGTON DM, O'Reilly M
    The reimagination of school-based physical activity research in the COVID-19 era.
    PLoS Med. 2020;17:e1003267.
    PubMed     Abstract available
    
    
    July 2020
94. SAVICKAS V, Stewart AJ, Rees-Roberts M, Short V, et al
    Opportunistic screening for atrial fibrillation by clinical pharmacists in UK general practice during the influenza vaccination season: A cross-sectional feasibility study.
    PLoS Med. 2020;17:e1003197.
    PubMed     Abstract available
    
    
    
95. TESLYA A, Pham TM, Godijk NG, Kretzschmar ME, et al
    Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study.
    PLoS Med. 2020;17:e1003166.
    PubMed     Abstract available
    
    
    
96. PINOTTI F, Di Domenico L, Ortega E, Mancastroppa M, et al
    Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study.
    PLoS Med. 2020;17:e1003193.
    PubMed     Abstract available
    
    
    
97. WU YT, Liu J, Xu JJ, Chen YF, et al
    Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China.
    PLoS Med. 2020;17:e1003195.
    PubMed     Abstract available
    
    
    
98. HAUSER A, Counotte MJ, Margossian CC, Konstantinoudis G, et al
    Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    PLoS Med. 2020;17:e1003189.
    PubMed     Abstract available
    
    
    
99. ZHANG L, Tao Y, Shen M, Fairley CK, et al
    Can self-imposed prevention measures mitigate the COVID-19 epidemic?
    PLoS Med. 2020;17:e1003240.
    PubMed     Abstract available
    
    
    
100. ADAMS J
     Addressing socioeconomic inequalities in obesity: Democratising access to resources for achieving and maintaining a healthy weight.
     PLoS Med. 2020;17:e1003243.
     PubMed    
     
     
     June 2020
101. TRUELOVE S, Abrahim O, Altare C, Lauer SA, et al
     The potential impact of COVID-19 in refugee camps in Bangladesh and beyond: A modeling study.
     PLoS Med. 2020;17:e1003144.
     PubMed     Abstract available
     
     
     
102. ZHANG C, Gu J, Chen Q, Deng N, et al
     Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series.
     PLoS Med. 2020;17:e1003130.
     PubMed     Abstract available
     
     
     
103. GREENHALGH T
     Will COVID-19 be evidence-based medicine's nemesis?
     PLoS Med. 2020;17:e1003266.
     PubMed    
     
     
     May 2020
104. KAZATCHKINE MD, Goldman M, Vincent JL
     Antibody-based therapies for COVID-19: Can Europe move faster?
     PLoS Med. 2020;17:e1003127.
     PubMed     Abstract available
     
     
     
105. 
     Pandemic preparedness and responses: WHO to turn to in a crisis?
     PLoS Med. 2020;17:e1003167.
     PubMed     Abstract available
     
     
     April 2020
106. 
     Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks.
     PLoS Med. 2020;17:e1003123.
     PubMed     Abstract available
     
     
     March 2020
107. FORSTER AH, Witham K, Depelsenaire ACI, Veitch M, et al
     Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
     PLoS Med. 2020;17:e1003024.
     PubMed     Abstract available
     
     
     January 2020
108. SHEARER FM, Moss R, McVernon J, Ross JV, et al
     Infectious disease pandemic planning and response: Incorporating decision analysis.
     PLoS Med. 2020;17:e1003018.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: